Medicines for Malaria Venture
We discover, develop and deliver malaria medicines tailored to the populations they serve.
The report reveals some important global challenges, including climate change, as progress against the disease continues to stagnate.
Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings.
MMV is delighted to hear of Dr. David Fidock’s selection as President-Elect of The American Society of Tropical Medicine and Hygiene (ASTMH).
Since 2020, several studies have confirmed the emergence of partial artemisinin resistance – a delay in the time it takes for treatments to successfully clear the parasite - in a growing number of African countries. This presents a significant threat to efforts to control and eliminate malaria in Africa.
Digital Annual Report 2022
Defeating malaria while reinforcing diversity, equity and inclusion
Throughout 2022, MMV continued working with our partners to bring forward antimalarials to protect and cure the world’s most underserved populations, enhance control efforts and progress toward the eventual eradication and elimination of the disease globally. Our latest annual report offers an in-depth overview of MMV’s activities, achievements and financial statements for 2022. Read more.
Digital Annual Report 2022
Throughout 2022, MMV continued working with our partners to bring forward antimalarials to protect and cure the world’s most underserved populations, enhance control efforts and progress toward the eventual eradication of the disease globally. Our latest annual report offers an in-depth overview of MMV’s activities, achievements and financial statements for 2022. Read more.
A gender-transformative approach
Women and girls are uniquely affected by malaria's health, economic and societal impacts. Malaria means a heightened risk of morbidity and mortality for pregnant women and girls and their newborns. This, in turn, contributes to keeping women and girls away from school and work, exacerbating gender inequalities in education and in the workplace, and ultimately intensifying gendered power imbalances in society. MMV works to remedy this with the Malaria in Mothers and Babies (MiMBa) strategy. Read more.
Health systems strengthening
Preparing for the next global disease outbreak
Before the COVID-19 pandemic, the term “global health” was often used with reference to low-and-middle-income countries. If the past two years have taught us anything, it is that we are all “global health”—North or South, microbes and particles connect us all, yet resources are unevenly distributed. Investments in combatting diseases that often occur amongst the poorest populations allow countries to build more resilient health systems. These systems can be deployed in response to the next global health emergency. Read more.